TREA

78420082 - HIT

Follow

Information

  • Trademark
  • 78420082
  • Serial Number
    78420082
  • Filing Date
    May 17, 2004
    20 years ago
  • Transaction Date
    July 15, 2005
    19 years ago
  • Status Date
    July 07, 2005
    19 years ago
  • Location Date
    January 03, 2005
    20 years ago
  • Status Code
    601
  • Current Location
    TMO LAW OFFICE 116
    Employee Name
    BROWN, BARBARA TROFFKI
  • Attorney Docket Number
    KAS-TM012
    Attorney Name
    John J. O'Malley
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
HIT
Case File Statements
  • GS0051: Pharmaceutical preparations adapted for the topical, injectable, and intravenous treatment of the following, cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sores, shingles; renal failure, cardiac insufficiency, hypertension, oedema; infection, acne, mononucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification, brochodilation; vascular ischemia; HIV(AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthritis or pannus; cancer tumors; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumors; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumor of the skin; genital warts (condyloma acuminata); cervical cancer; human papilloma virus (HVP); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infiltration; pharmaceutical preparations comprising hyaluronan; licensing of intellectual property technology and research and developing for others, regarding pharmaceutical preparations, including pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of medical conditions and disease in humans
Case File Event Statements
  • 7/8/2005 - 19 years ago
    7 - ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Type: MAB1
  • 7/7/2005 - 19 years ago
    6 - ABANDONMENT - EXPRESS MAILED Type: ABN1
  • 7/5/2005 - 19 years ago
    5 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 1/3/2005 - 20 years ago
    4 - NON-FINAL ACTION MAILED Type: CNRT
  • 1/3/2005 - 20 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/15/2004 - 20 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/24/2004 - 20 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP